Drug Interactions between elbasvir / grazoprevir and Naproxen Sodium DS
This report displays the potential drug interactions for the following 2 drugs:
- elbasvir/grazoprevir
- Naproxen Sodium DS (naproxen)
Interactions between your drugs
No interactions were found between elbasvir / grazoprevir and Naproxen Sodium DS. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
elbasvir / grazoprevir
A total of 227 drugs are known to interact with elbasvir / grazoprevir.
- Elbasvir / grazoprevir is in the drug class antiviral combinations.
- Elbasvir / grazoprevir is used to treat Hepatitis C.
Naproxen Sodium DS
A total of 428 drugs are known to interact with Naproxen Sodium DS.
- Naproxen sodium ds is in the drug class Nonsteroidal anti-inflammatory drugs.
-
Naproxen sodium ds is used to treat the following conditions:
- Ankylosing Spondylitis
- Aseptic Necrosis (off-label)
- Back Pain
- Bursitis
- Chronic Myofascial Pain
- Costochondritis
- Diffuse Idiopathic Skeletal Hyperostosis
- Dysautonomia
- Fever
- Frozen Shoulder
- Gout, Acute
- Headache
- Muscle Pain
- Neck Pain
- Osteoarthritis
- Pain
- Period Pain
- Rheumatoid Arthritis
- Sciatica
- Spondylolisthesis
- Tendonitis
Drug and food interactions
naproxen food
Applies to: Naproxen Sodium DS (naproxen)
GENERALLY AVOID: The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss. The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.
MANAGEMENT: Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.
References
- (2002) "Product Information. Motrin (ibuprofen)." Pharmacia and Upjohn
grazoprevir food
Applies to: elbasvir / grazoprevir
Food does not appear to have clinically significant effects on the pharmacokinetics of elbasvir and grazoprevir. When a single 50 mg-100 mg dose of elbasvir-grazoprevir was administered to healthy study subjects with a high-fat meal (900 kcal; 500 kcal from fat), elbasvir peak plasma concentration (Cmax) and systemic exposure (AUC) decreased by 15% and 11%, respectively, while grazoprevir Cmax and AUC increased by 2.8- and 1.5-fold, respectively, compared to administration under fasting conditions. According to the product labeling, elbasvir-grazoprevir may be administered with or without food.
References
- (2016) "Product Information. Zepatier (elbasvir-grazoprevir)." Merck & Co., Inc
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.